The Memphis Grizzlies remain uncertain about when star guard Ja Morant will return to play this season, following his injury in late January. Despite the NBA trade deadline passing with Memphis choosing to retain Morant, his recovery timeline remains unclear, as the team awaits medical evaluations to determine his availability.
General manager Zach Kleiman addressed questions about Morant’s status after the deadline, emphasizing that the final decision is medical. Drew Hill of The Daily Memphian shared on X that Kleiman said, “It’s a medical determination.”
Details of Morant’s Injury and Season Performance Before the Setback
Morant has not played since suffering a UCL sprain in his left elbow, an injury that led to an initial estimated recovery period of at least three weeks, with ongoing assessments planned. Before the injury, Morant appeared in 20 games this season, posting averages of 19.5 points, 8.1 assists, 3.5 rebounds, and one steal per game. His shooting percentages included 41 percent from the field and a career-low 23.5 percent from three-point range, while he achieved a career-high free-throw percentage of 89.7.
This season’s scoring average is the lowest since 2020-21, reflecting the difficulties Morant has faced with injuries and inconsistency. The Grizzlies continue to hope for a full recovery but are prepared for a longer-term absence if needed.
Grizzlies’ Roster Moves Highlight Transition Amid Morant’s Recovery
The uncertainty over Morant’s return has coincided with a major roster overhaul by Memphis. Prior to the trade deadline, the team traded Jaren Jackson Jr. to the Utah Jazz in a deal that brought in three future first-round draft picks and players Walter Clayton Jr., Kyle Anderson, Taylor Hendricks, and Georges Niang. The deal also included John Konchar, Jock Landale, and Vince Williams Jr.
With a current record of 20-29 and positioned 11th in the Western Conference, the Grizzlies continue to navigate a challenging season filled with transitions and unanswered questions around their franchise leader. Their next scheduled game is against the Portland Trail Blazers, who hold a 23-28 record, as Memphis works to adjust through ongoing roster and injury challenges.
Implications of Morant’s Injury for Team’s Future Prospects
Ja Morant’s ongoing recovery and uncertain return date pose significant challenges for the Memphis Grizzlies’ season outlook and rebuilding strategy. The team’s substantial roster changes suggest a shift toward a longer-term plan, recognizing the need to adjust without immediate access to their key player. How quickly Morant can return, and at what level of performance, will be critical for Memphis’s ambitions in a competitive Western Conference.
Kleiman being pressed on if Ja will play this season.
"It's a medical determination."
— Drew Hill (@DrewHill_DM) February 6, 2026
